Last reviewed · How we verify

Safety of Cell-free Adipose Tissue Product in Healthy Volunteers (SAFETY)

NCT05518084 NA COMPLETED

The study is a randomized, double blinded, bilaterally controlled trial.The aim is to evaluate the short- and mid term safety of cell-free adipose tissue product. The safety of the tissue product is to be studied in 40 healthy volunteers. Cell-free tissue product is injected into superficial part of the subcutis with one injection to standardized area. The volume of the injection is 4,5 ml. As the control method, the same size area is injected with plain Ringer-Acetat solution. The adverse events and serious adverse events are monitored in doctor visits, phone calls and e-diary.

Details

Lead sponsorLinio Biotech Oy
PhaseNA
StatusCOMPLETED
Enrolment38
Start dateWed Aug 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionWed Feb 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Finland